ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Radioactive Therapeutic Drugs Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-12N15953
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Radioactive Therapeutic Drugs Market Research Report 2023
BUY CHAPTERS

Global Radioactive Therapeutic Drugs Market Research Report 2025

Code: QYRE-Auto-12N15953
Report
May 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Nihon Medi-Physics
ITM Isotopen Technologien München AG
Advanced Accelerator Applications
GE Healthcare
Theragnostics
NuView Life Sciences
Jubilant Pharma Limited
Curium Pharma
Bayer
Clarity Pharmaceuticals
Lantheus Holdings, Inc
Telix Pharmaceuticals

Radioactive Therapeutic Drugs Market

The global market for Radioactive Therapeutic Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Nuclear medicine therapy uses radiopharmaceuticals targeting specific tumors, such as thyroid tumors, lymphomas, or bone metastases, to deliver radiation to neoplastic lesions as part of a therapeutic strategy to cure, alleviate, or control the disease.
North American market for Radioactive Therapeutic Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Radioactive Therapeutic Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Radioactive Therapeutic Drugs in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Radioactive Therapeutic Drugs include Nihon Medi-Physics, ITM Isotopen Technologien München AG, Advanced Accelerator Applications, Telix Pharmaceuticals, GE Healthcare, Theragnostics Ltd., NuView Life Sciences, Jubilant Pharma Limited, Lantheus Holdings, Inc., Curium Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Radioactive Therapeutic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radioactive Therapeutic Drugs.
The Radioactive Therapeutic Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Radioactive Therapeutic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radioactive Therapeutic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Radioactive Therapeutic Drugs Market Report

Report Metric Details
Report Name Radioactive Therapeutic Drugs Market
Segment by Type
Segment by Application
  • Hospitals
  • Academic & Research Institutes
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Nihon Medi-Physics, ITM Isotopen Technologien München AG, Advanced Accelerator Applications, Telix Pharmaceuticals, GE Healthcare, Theragnostics Ltd., NuView Life Sciences, Jubilant Pharma Limited, Lantheus Holdings, Inc., Curium Pharma, Bayer AG, Clarity Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Radioactive Therapeutic Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Radioactive Therapeutic Drugs Market report?

Ans: The main players in the Radioactive Therapeutic Drugs Market are Nihon Medi-Physics, ITM Isotopen Technologien München AG, Advanced Accelerator Applications, Telix Pharmaceuticals, GE Healthcare, Theragnostics Ltd., NuView Life Sciences, Jubilant Pharma Limited, Lantheus Holdings, Inc., Curium Pharma, Bayer AG, Clarity Pharmaceuticals

What are the Application segmentation covered in the Radioactive Therapeutic Drugs Market report?

Ans: The Applications covered in the Radioactive Therapeutic Drugs Market report are Hospitals, Academic & Research Institutes, Others

What are the Type segmentation covered in the Radioactive Therapeutic Drugs Market report?

Ans: The Types covered in the Radioactive Therapeutic Drugs Market report are Oncology, Cardiology, Others

Recommended Reports

Radiotherapy & Devices

Radiopharmaceuticals Market

Medical Isotopes

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radioactive Therapeutic Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oncology
1.2.3 Cardiology
1.2.4 Others
1.3 Market by Application
1.3.1 Global Radioactive Therapeutic Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Academic & Research Institutes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radioactive Therapeutic Drugs Market Perspective (2020-2031)
2.2 Global Radioactive Therapeutic Drugs Growth Trends by Region
2.2.1 Global Radioactive Therapeutic Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Radioactive Therapeutic Drugs Historic Market Size by Region (2020-2025)
2.2.3 Radioactive Therapeutic Drugs Forecasted Market Size by Region (2026-2031)
2.3 Radioactive Therapeutic Drugs Market Dynamics
2.3.1 Radioactive Therapeutic Drugs Industry Trends
2.3.2 Radioactive Therapeutic Drugs Market Drivers
2.3.3 Radioactive Therapeutic Drugs Market Challenges
2.3.4 Radioactive Therapeutic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radioactive Therapeutic Drugs Players by Revenue
3.1.1 Global Top Radioactive Therapeutic Drugs Players by Revenue (2020-2025)
3.1.2 Global Radioactive Therapeutic Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Radioactive Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Radioactive Therapeutic Drugs Revenue
3.4 Global Radioactive Therapeutic Drugs Market Concentration Ratio
3.4.1 Global Radioactive Therapeutic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radioactive Therapeutic Drugs Revenue in 2024
3.5 Global Key Players of Radioactive Therapeutic Drugs Head office and Area Served
3.6 Global Key Players of Radioactive Therapeutic Drugs, Product and Application
3.7 Global Key Players of Radioactive Therapeutic Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Radioactive Therapeutic Drugs Breakdown Data by Type
4.1 Global Radioactive Therapeutic Drugs Historic Market Size by Type (2020-2025)
4.2 Global Radioactive Therapeutic Drugs Forecasted Market Size by Type (2026-2031)
5 Radioactive Therapeutic Drugs Breakdown Data by Application
5.1 Global Radioactive Therapeutic Drugs Historic Market Size by Application (2020-2025)
5.2 Global Radioactive Therapeutic Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Radioactive Therapeutic Drugs Market Size (2020-2031)
6.2 North America Radioactive Therapeutic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Radioactive Therapeutic Drugs Market Size by Country (2020-2025)
6.4 North America Radioactive Therapeutic Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radioactive Therapeutic Drugs Market Size (2020-2031)
7.2 Europe Radioactive Therapeutic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Radioactive Therapeutic Drugs Market Size by Country (2020-2025)
7.4 Europe Radioactive Therapeutic Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radioactive Therapeutic Drugs Market Size (2020-2031)
8.2 Asia-Pacific Radioactive Therapeutic Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Radioactive Therapeutic Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Radioactive Therapeutic Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Radioactive Therapeutic Drugs Market Size (2020-2031)
9.2 Latin America Radioactive Therapeutic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Radioactive Therapeutic Drugs Market Size by Country (2020-2025)
9.4 Latin America Radioactive Therapeutic Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radioactive Therapeutic Drugs Market Size (2020-2031)
10.2 Middle East & Africa Radioactive Therapeutic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Radioactive Therapeutic Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Radioactive Therapeutic Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Nihon Medi-Physics
11.1.1 Nihon Medi-Physics Company Details
11.1.2 Nihon Medi-Physics Business Overview
11.1.3 Nihon Medi-Physics Radioactive Therapeutic Drugs Introduction
11.1.4 Nihon Medi-Physics Revenue in Radioactive Therapeutic Drugs Business (2020-2025)
11.1.5 Nihon Medi-Physics Recent Development
11.2 ITM Isotopen Technologien München AG
11.2.1 ITM Isotopen Technologien München AG Company Details
11.2.2 ITM Isotopen Technologien München AG Business Overview
11.2.3 ITM Isotopen Technologien München AG Radioactive Therapeutic Drugs Introduction
11.2.4 ITM Isotopen Technologien München AG Revenue in Radioactive Therapeutic Drugs Business (2020-2025)
11.2.5 ITM Isotopen Technologien München AG Recent Development
11.3 Advanced Accelerator Applications
11.3.1 Advanced Accelerator Applications Company Details
11.3.2 Advanced Accelerator Applications Business Overview
11.3.3 Advanced Accelerator Applications Radioactive Therapeutic Drugs Introduction
11.3.4 Advanced Accelerator Applications Revenue in Radioactive Therapeutic Drugs Business (2020-2025)
11.3.5 Advanced Accelerator Applications Recent Development
11.4 Telix Pharmaceuticals
11.4.1 Telix Pharmaceuticals Company Details
11.4.2 Telix Pharmaceuticals Business Overview
11.4.3 Telix Pharmaceuticals Radioactive Therapeutic Drugs Introduction
11.4.4 Telix Pharmaceuticals Revenue in Radioactive Therapeutic Drugs Business (2020-2025)
11.4.5 Telix Pharmaceuticals Recent Development
11.5 GE Healthcare
11.5.1 GE Healthcare Company Details
11.5.2 GE Healthcare Business Overview
11.5.3 GE Healthcare Radioactive Therapeutic Drugs Introduction
11.5.4 GE Healthcare Revenue in Radioactive Therapeutic Drugs Business (2020-2025)
11.5.5 GE Healthcare Recent Development
11.6 Theragnostics Ltd.
11.6.1 Theragnostics Ltd. Company Details
11.6.2 Theragnostics Ltd. Business Overview
11.6.3 Theragnostics Ltd. Radioactive Therapeutic Drugs Introduction
11.6.4 Theragnostics Ltd. Revenue in Radioactive Therapeutic Drugs Business (2020-2025)
11.6.5 Theragnostics Ltd. Recent Development
11.7 NuView Life Sciences
11.7.1 NuView Life Sciences Company Details
11.7.2 NuView Life Sciences Business Overview
11.7.3 NuView Life Sciences Radioactive Therapeutic Drugs Introduction
11.7.4 NuView Life Sciences Revenue in Radioactive Therapeutic Drugs Business (2020-2025)
11.7.5 NuView Life Sciences Recent Development
11.8 Jubilant Pharma Limited
11.8.1 Jubilant Pharma Limited Company Details
11.8.2 Jubilant Pharma Limited Business Overview
11.8.3 Jubilant Pharma Limited Radioactive Therapeutic Drugs Introduction
11.8.4 Jubilant Pharma Limited Revenue in Radioactive Therapeutic Drugs Business (2020-2025)
11.8.5 Jubilant Pharma Limited Recent Development
11.9 Lantheus Holdings, Inc.
11.9.1 Lantheus Holdings, Inc. Company Details
11.9.2 Lantheus Holdings, Inc. Business Overview
11.9.3 Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Introduction
11.9.4 Lantheus Holdings, Inc. Revenue in Radioactive Therapeutic Drugs Business (2020-2025)
11.9.5 Lantheus Holdings, Inc. Recent Development
11.10 Curium Pharma
11.10.1 Curium Pharma Company Details
11.10.2 Curium Pharma Business Overview
11.10.3 Curium Pharma Radioactive Therapeutic Drugs Introduction
11.10.4 Curium Pharma Revenue in Radioactive Therapeutic Drugs Business (2020-2025)
11.10.5 Curium Pharma Recent Development
11.11 Bayer AG
11.11.1 Bayer AG Company Details
11.11.2 Bayer AG Business Overview
11.11.3 Bayer AG Radioactive Therapeutic Drugs Introduction
11.11.4 Bayer AG Revenue in Radioactive Therapeutic Drugs Business (2020-2025)
11.11.5 Bayer AG Recent Development
11.12 Clarity Pharmaceuticals
11.12.1 Clarity Pharmaceuticals Company Details
11.12.2 Clarity Pharmaceuticals Business Overview
11.12.3 Clarity Pharmaceuticals Radioactive Therapeutic Drugs Introduction
11.12.4 Clarity Pharmaceuticals Revenue in Radioactive Therapeutic Drugs Business (2020-2025)
11.12.5 Clarity Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Nihon Medi-Physics
ITM Isotopen Technologien München AG
Advanced Accelerator Applications
GE Healthcare
Theragnostics
NuView Life Sciences
Jubilant Pharma Limited
Curium Pharma
Bayer
Clarity Pharmaceuticals
Lantheus Holdings, Inc
Telix Pharmaceuticals
List of Tables
 Table 1. Global Radioactive Therapeutic Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Oncology
 Table 3. Key Players of Cardiology
 Table 4. Key Players of Others
 Table 5. Global Radioactive Therapeutic Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Radioactive Therapeutic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Radioactive Therapeutic Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Radioactive Therapeutic Drugs Market Share by Region (2020-2025)
 Table 9. Global Radioactive Therapeutic Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Radioactive Therapeutic Drugs Market Share by Region (2026-2031)
 Table 11. Radioactive Therapeutic Drugs Market Trends
 Table 12. Radioactive Therapeutic Drugs Market Drivers
 Table 13. Radioactive Therapeutic Drugs Market Challenges
 Table 14. Radioactive Therapeutic Drugs Market Restraints
 Table 15. Global Radioactive Therapeutic Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Radioactive Therapeutic Drugs Market Share by Players (2020-2025)
 Table 17. Global Top Radioactive Therapeutic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioactive Therapeutic Drugs as of 2024)
 Table 18. Ranking of Global Top Radioactive Therapeutic Drugs Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Radioactive Therapeutic Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Radioactive Therapeutic Drugs, Headquarters and Area Served
 Table 21. Global Key Players of Radioactive Therapeutic Drugs, Product and Application
 Table 22. Global Key Players of Radioactive Therapeutic Drugs, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Radioactive Therapeutic Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Radioactive Therapeutic Drugs Revenue Market Share by Type (2020-2025)
 Table 26. Global Radioactive Therapeutic Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Radioactive Therapeutic Drugs Revenue Market Share by Type (2026-2031)
 Table 28. Global Radioactive Therapeutic Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Radioactive Therapeutic Drugs Revenue Market Share by Application (2020-2025)
 Table 30. Global Radioactive Therapeutic Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Radioactive Therapeutic Drugs Revenue Market Share by Application (2026-2031)
 Table 32. North America Radioactive Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Radioactive Therapeutic Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Radioactive Therapeutic Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Radioactive Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Radioactive Therapeutic Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Radioactive Therapeutic Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Radioactive Therapeutic Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Radioactive Therapeutic Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Radioactive Therapeutic Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Radioactive Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Radioactive Therapeutic Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Radioactive Therapeutic Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Radioactive Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Radioactive Therapeutic Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Radioactive Therapeutic Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Nihon Medi-Physics Company Details
 Table 48. Nihon Medi-Physics Business Overview
 Table 49. Nihon Medi-Physics Radioactive Therapeutic Drugs Product
 Table 50. Nihon Medi-Physics Revenue in Radioactive Therapeutic Drugs Business (2020-2025) & (US$ Million)
 Table 51. Nihon Medi-Physics Recent Development
 Table 52. ITM Isotopen Technologien München AG Company Details
 Table 53. ITM Isotopen Technologien München AG Business Overview
 Table 54. ITM Isotopen Technologien München AG Radioactive Therapeutic Drugs Product
 Table 55. ITM Isotopen Technologien München AG Revenue in Radioactive Therapeutic Drugs Business (2020-2025) & (US$ Million)
 Table 56. ITM Isotopen Technologien München AG Recent Development
 Table 57. Advanced Accelerator Applications Company Details
 Table 58. Advanced Accelerator Applications Business Overview
 Table 59. Advanced Accelerator Applications Radioactive Therapeutic Drugs Product
 Table 60. Advanced Accelerator Applications Revenue in Radioactive Therapeutic Drugs Business (2020-2025) & (US$ Million)
 Table 61. Advanced Accelerator Applications Recent Development
 Table 62. Telix Pharmaceuticals Company Details
 Table 63. Telix Pharmaceuticals Business Overview
 Table 64. Telix Pharmaceuticals Radioactive Therapeutic Drugs Product
 Table 65. Telix Pharmaceuticals Revenue in Radioactive Therapeutic Drugs Business (2020-2025) & (US$ Million)
 Table 66. Telix Pharmaceuticals Recent Development
 Table 67. GE Healthcare Company Details
 Table 68. GE Healthcare Business Overview
 Table 69. GE Healthcare Radioactive Therapeutic Drugs Product
 Table 70. GE Healthcare Revenue in Radioactive Therapeutic Drugs Business (2020-2025) & (US$ Million)
 Table 71. GE Healthcare Recent Development
 Table 72. Theragnostics Ltd. Company Details
 Table 73. Theragnostics Ltd. Business Overview
 Table 74. Theragnostics Ltd. Radioactive Therapeutic Drugs Product
 Table 75. Theragnostics Ltd. Revenue in Radioactive Therapeutic Drugs Business (2020-2025) & (US$ Million)
 Table 76. Theragnostics Ltd. Recent Development
 Table 77. NuView Life Sciences Company Details
 Table 78. NuView Life Sciences Business Overview
 Table 79. NuView Life Sciences Radioactive Therapeutic Drugs Product
 Table 80. NuView Life Sciences Revenue in Radioactive Therapeutic Drugs Business (2020-2025) & (US$ Million)
 Table 81. NuView Life Sciences Recent Development
 Table 82. Jubilant Pharma Limited Company Details
 Table 83. Jubilant Pharma Limited Business Overview
 Table 84. Jubilant Pharma Limited Radioactive Therapeutic Drugs Product
 Table 85. Jubilant Pharma Limited Revenue in Radioactive Therapeutic Drugs Business (2020-2025) & (US$ Million)
 Table 86. Jubilant Pharma Limited Recent Development
 Table 87. Lantheus Holdings, Inc. Company Details
 Table 88. Lantheus Holdings, Inc. Business Overview
 Table 89. Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Product
 Table 90. Lantheus Holdings, Inc. Revenue in Radioactive Therapeutic Drugs Business (2020-2025) & (US$ Million)
 Table 91. Lantheus Holdings, Inc. Recent Development
 Table 92. Curium Pharma Company Details
 Table 93. Curium Pharma Business Overview
 Table 94. Curium Pharma Radioactive Therapeutic Drugs Product
 Table 95. Curium Pharma Revenue in Radioactive Therapeutic Drugs Business (2020-2025) & (US$ Million)
 Table 96. Curium Pharma Recent Development
 Table 97. Bayer AG Company Details
 Table 98. Bayer AG Business Overview
 Table 99. Bayer AG Radioactive Therapeutic Drugs Product
 Table 100. Bayer AG Revenue in Radioactive Therapeutic Drugs Business (2020-2025) & (US$ Million)
 Table 101. Bayer AG Recent Development
 Table 102. Clarity Pharmaceuticals Company Details
 Table 103. Clarity Pharmaceuticals Business Overview
 Table 104. Clarity Pharmaceuticals Radioactive Therapeutic Drugs Product
 Table 105. Clarity Pharmaceuticals Revenue in Radioactive Therapeutic Drugs Business (2020-2025) & (US$ Million)
 Table 106. Clarity Pharmaceuticals Recent Development
 Table 107. Research Programs/Design for This Report
 Table 108. Key Data Information from Secondary Sources
 Table 109. Key Data Information from Primary Sources
 Table 110. Authors List of This Report


List of Figures
 Figure 1. Radioactive Therapeutic Drugs Picture
 Figure 2. Global Radioactive Therapeutic Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Radioactive Therapeutic Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Oncology Features
 Figure 5. Cardiology Features
 Figure 6. Others Features
 Figure 7. Global Radioactive Therapeutic Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Radioactive Therapeutic Drugs Market Share by Application: 2024 VS 2031
 Figure 9. Hospitals Case Studies
 Figure 10. Academic & Research Institutes Case Studies
 Figure 11. Others Case Studies
 Figure 12. Radioactive Therapeutic Drugs Report Years Considered
 Figure 13. Global Radioactive Therapeutic Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Radioactive Therapeutic Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Radioactive Therapeutic Drugs Market Share by Region: 2024 VS 2031
 Figure 16. Global Radioactive Therapeutic Drugs Market Share by Players in 2024
 Figure 17. Global Top Radioactive Therapeutic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioactive Therapeutic Drugs as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Radioactive Therapeutic Drugs Revenue in 2024
 Figure 19. North America Radioactive Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Radioactive Therapeutic Drugs Market Share by Country (2020-2031)
 Figure 21. United States Radioactive Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Radioactive Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Radioactive Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Radioactive Therapeutic Drugs Market Share by Country (2020-2031)
 Figure 25. Germany Radioactive Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Radioactive Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Radioactive Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Radioactive Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Radioactive Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Radioactive Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Radioactive Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Radioactive Therapeutic Drugs Market Share by Region (2020-2031)
 Figure 33. China Radioactive Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Radioactive Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Radioactive Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Radioactive Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Radioactive Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Radioactive Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Radioactive Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Radioactive Therapeutic Drugs Market Share by Country (2020-2031)
 Figure 41. Mexico Radioactive Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Radioactive Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Radioactive Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Radioactive Therapeutic Drugs Market Share by Country (2020-2031)
 Figure 45. Turkey Radioactive Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Radioactive Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Radioactive Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Nihon Medi-Physics Revenue Growth Rate in Radioactive Therapeutic Drugs Business (2020-2025)
 Figure 49. ITM Isotopen Technologien München AG Revenue Growth Rate in Radioactive Therapeutic Drugs Business (2020-2025)
 Figure 50. Advanced Accelerator Applications Revenue Growth Rate in Radioactive Therapeutic Drugs Business (2020-2025)
 Figure 51. Telix Pharmaceuticals Revenue Growth Rate in Radioactive Therapeutic Drugs Business (2020-2025)
 Figure 52. GE Healthcare Revenue Growth Rate in Radioactive Therapeutic Drugs Business (2020-2025)
 Figure 53. Theragnostics Ltd. Revenue Growth Rate in Radioactive Therapeutic Drugs Business (2020-2025)
 Figure 54. NuView Life Sciences Revenue Growth Rate in Radioactive Therapeutic Drugs Business (2020-2025)
 Figure 55. Jubilant Pharma Limited Revenue Growth Rate in Radioactive Therapeutic Drugs Business (2020-2025)
 Figure 56. Lantheus Holdings, Inc. Revenue Growth Rate in Radioactive Therapeutic Drugs Business (2020-2025)
 Figure 57. Curium Pharma Revenue Growth Rate in Radioactive Therapeutic Drugs Business (2020-2025)
 Figure 58. Bayer AG Revenue Growth Rate in Radioactive Therapeutic Drugs Business (2020-2025)
 Figure 59. Clarity Pharmaceuticals Revenue Growth Rate in Radioactive Therapeutic Drugs Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Radiopharmaceutical Theranostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Radiopharmaceutical Therapy Market Research Report 2025
Nuclear Medicine Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Radiology Drug Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Therapeutic Nuclear Medicines Market Insights Forecast to 2030
Radiopharmaceuticals for Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Therapeutic Nuclear Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Therapeutic Radiopharmaceuticals Market Insights Forecast to 2030
Global Radiopharmaceuticals in Nuclear Medicine Market Research Report 2025
Nuclear Drug for Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nuclear Medicine Radiopharmaceuticals Market Research Report 2024
Global Nuclear Medicine Market Research Report 2025
Global Therapeutic Radioisotopes Market Insights Forecast to 2030
Global Radioisotopes in Medicine Market Research Report 2025
Global Nuclear Medicine Radioisotopes Market Insights Forecast to 2030
Global SPECT and PET Radiopharmaceuticals Market Research Report 2024
Global Medical Radioisotopes Market Research Report 2025
Global Diagnostic Nuclear Medicines Market Insights Forecast to 2030
Global Radiopharmaceutical Market Research Report 2025
Global Targeted Radiotherapy Drug Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions